Page last updated: 2024-10-29

iohexol and Brain Infarction

iohexol has been researched along with Brain Infarction in 1 studies

Iohexol: An effective non-ionic, water-soluble contrast agent which is used in myelography, arthrography, nephroangiography, arteriography, and other radiographic procedures. Its low systemic toxicity is the combined result of low chemotoxicity and low osmolality.
iohexol : A benzenedicarboxamide compound having N-(2,3-dihydroxypropyl)carbamoyl groups at the 1- and 3-positions, iodo substituents at the 2-, 4- and 6-positions and an N-(2,3-dihydroxypropyl)acetamido group at the 5-position.

Brain Infarction: Tissue NECROSIS in any area of the brain, including the CEREBRAL HEMISPHERES, the CEREBELLUM, and the BRAIN STEM. Brain infarction is the result of a cascade of events initiated by inadequate blood flow through the brain that is followed by HYPOXIA and HYPOGLYCEMIA in brain tissue. Damage may be temporary, permanent, selective or pan-necrosis.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Palomäki, H1
Muuronen, A1
Raininko, R1
Piilonen, A1
Kaste, M1

Other Studies

1 other study available for iohexol and Brain Infarction

ArticleYear
Administration of nonionic iodinated contrast medium does not influence the outcome of patients with ischemic brain infarction.
    Cerebrovascular diseases (Basel, Switzerland), 2003, Volume: 15, Issue:1-2

    Topics: Age Factors; Aged; Brain Infarction; Brain Ischemia; Contrast Media; Disability Evaluation; Female;

2003